Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Sotac Pharmaceuticals Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Sotac Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Sotac Pharmaceutical - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2025, 4:05PM Sotac Pharmaceuticals Limited has informed the Exchange about Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulatio
  • Sotac Pharmaceutical - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

    9 Jul 2025, 4:03PM Sotac Pharmaceuticals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
  • Sotac Pharmaceutical - Disclosure under SEBI Takeover Regulations

    25 Jun 2025, 7:52PM ÿSharadkumar Dashrathbhai Patelÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi
  • Sotac Pharmaceutical - Structural Digital Database

    30 May 2025, 6:47PM Submission of Structural Digital Database Compliance Certificate under SEBI (Prohibition of Insider Trading) Regulations, 2015, for the year ended 31s
  • Sotac Pharmaceutical - Outcome of Board Meeting-XBRL

    28 May 2025, 7:05PM Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on 28-May-2025 for Dividend
  • Sotac Pharmaceutical - Dividend

    28 May 2025, 6:53PM Sotac Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 28, 2025, recommended Final Dividend of Rs.
  • Sotac Pharmaceutical - Outcome of Board Meeting

    28 May 2025, 6:48PM Sotac Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
  • Sotac Pharmaceutical - Board Meeting Intimation

    23 May 2025, 12:15PM Sotac Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 28-May-2025 to consider and approve the Yearly Audited Finan
  • Sotac Pharmaceutical - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    22 May 2025, 7:05PM SOTAC PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transf
  • Sotac Pharmaceutical - Address Change

    22 May 2025, 7:04PM Sotac Pharmaceuticals Limited has informed the Exchange regarding change in Registered Office Address of the company.
  • Sotac Pharmaceutical - Appointment

    22 May 2025, 7:01PM Sotac Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms. Dimpal Dhebarbhai Patel, as Non- Executive Independent Director
  • Sotac Pharmaceutical - Outcome of Board Meeting

    22 May 2025, 6:57PM Sotac Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 22, 2025.
  • Sotac Pharmaceutical has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    19 Apr 2025, 7:11AM As of March 2025, 72.85% is owned by Indian Promoters and 27.15% by Public. <p align=justify> Top five Promoters holding highest number of shares of S

Key fundamentals

Evaluate the intrinsic value of Sotac Pharmaceuticals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 73.1572 59.4405 31.6484 14.0094 10.8993
Liabilities 73.1572 59.4405 31.6484 14.0094 10.8993
Equity 11.05 11.05 8.05 2.3 2.3
Gross Profit 7.6806 10.1947 8.208 6.1353 2.8012
Net Profit 4.7717 5.7488 4.4955 2.8786 0.8622
Cash From Operating Activities -6.082 -19.7894 8.5361 6.3507 2.3507
NPM(%) 7.64 8.56 7.75 3.93 1.98
Revenue 62.3842 67.105 57.9828 73.1517 43.4382
Expenses 54.7036 56.9103 49.7748 67.0164 40.637
ROE(%) 10.11 12.19 9.53 6.1 1.82

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Sotac Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 905.60 0.25 30.05 0.00 301.39 0.55
Lotus Eye Hospital and Institute Ltd 73.05 -1.14 208.71 0.00 3.55 0.00
Vaishali Pharma Ltd 12.76 -0.23 212.67 0.00 3.13 0.00
Astec Lifesciences Ltd 893.55 -0.53 0.00 0.00 -601.21 0.00

Company Info

The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Sotac Pharmaceuticals", pursuant to a deed of partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals" was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Sotac Pharmaceuticals Private Limited" and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to "Sotac Pharmaceuticals Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24230GJ2015PLC085451.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name "Sotac Pharmaceuticals Private Limited" Limited".2019- Recognised as "Fastest Growing Indian Company" with and Excellence Award by International Achievers Conference2021- Received "Indo Global award for Business Excellence"2022- The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.- The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.- The Company was converted into Public Limited Company under the name of "Sotac Pharmaceuticals Limited"- Received recognition as for "Fastest Expansion of Project" by Sanand Industries Association (SIA)- Recognized as one of the "Top 10 Pharma Contract Manufacturers in India" by India Pharma Outlook

The Company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 ("Partnership Act") in the name and style of "M/s Sotac Pharmaceuticals", pursuant to a deed of partnership dated October 28, 2015. Thereafter "M/s. Sotac Pharmaceuticals" was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of "Sotac Pharmaceuticals Private Limited" and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to "Sotac Pharmaceuticals Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of the Company is U24230GJ2015PLC085451.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name "Sotac Pharmaceuticals Private Limited" Limited".2019- Recognised as "Fastest Growing Indian Company" with and Excellence Award by International Achievers Conference2021- Received "Indo Global award for Business Excellence"2022- The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.- The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.- The Company was converted into Public Limited Company under the name of "Sotac Pharmaceuticals Limited"- Received recognition as for "Fastest Expansion of Project" by Sanand Industries Association (SIA)- Recognized as one of the "Top 10 Pharma Contract Manufacturers in India" by India Pharma Outlook

Read More

Parent Organisation

Sotac Pharmaceuticals Ltd

Founded

18/12/2015

Managing Director

Mr.Sharadkumar Dashrathbhai Patel

NSE Symbol

SOTACSM

FAQ

The current price of Sotac Pharmaceuticals Ltd is

The 52-week high for Sotac Pharmaceuticals Ltd is

The market capitalization of Sotac Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Sotac Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Sotac Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sotac Pharmaceuticals Ltd shares.

The CEO of Sotac Pharmaceuticals Ltd is Mr.Sharadkumar Dashrathbhai Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT